Use of midazolam in the treatment of refractory status epilepticus

Clinical Therapeutics

Volumn 20, Issue 6, 1998, Pages 1093-1105

  Hanley, Daniel F ^a,b   Kross, John F ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c NONE

Author keywords

Anticonvulsives; Benzodiazepines; Midazolam; Phenytoin; Refractory status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; FOSPHENYTOIN SODIUM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; THIOPENTAL;

ANTICONVULSANT ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE CLASSIFICATION; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG TOLERABILITY; EPILEPTIC STATE; GRAND MAL SEIZURE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHARMACODYNAMICS; RESPIRATION DEPRESSION;

EID: 0032447714     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(98)80106-9     Document Type: Conference Paper

References (44)

1. 1. Maytal J. The management of status epilepticus in children. Child Hosp Q. 1991;3:255-263.
2. 2. Jagoda A, Riggio S. Refractory status epilepticus in adults. Ann Emerg Med. 1993;22:1337-1348.
3. 3. Porter R. Recognizing and classifying epileptic seizures and epileptic syndromes. Neurol Clin. 1986;4:495-508.
4. 4. DeLorenzo RJ, Towne AR, Pellock JM, Ko D. Status epilepticus in children, adults and the elderly. Epilepsia. 1992;33(Suppl 4):S15-S25.
5. 5. Bleck TP. Advances in the management of refractory status epilepticus. Crit Care Med. 1993;21:955-957.
6. 6. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol. 1995;12:316-325.
7. 7. Rose B. Barbiturate therapy for status epilepticus in the postanesthesia care unit. J Post Anesth Nurs. 1994;9:334-339.
8. 8. Roberts MR, Eng-Bourquin J. Status epilepticus in children. Emerg Med Clin North Am. 1995;13:489-507.
9. 9. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22:489-501.
10. 10. Lowenstein DH, Aldredge BK. Status epilepticus. NEJM. 1998;338:970-976.
11. 11. Hauser WA. Status epilepticus: Epidemiologic considerations. Neurology. 1990;40(Suppl 2):9-13.
12. 12. Gross-Tsur V, Shinnar S. Convulsive status epilepticus in children. Epilepsia. 1993;34(Suppl 1):S12-S20.
13. 13. Bone RC. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA. 1993;270:854-859.
14. 14. Treiman DM. Generalized convulsive status epilepticus in the adult. Epilepsia. 1993;34(Suppl 1):S2-S11.
15. 15. Delgado-Escueta AV, Bajorek JG. Status epilepticus: Mechanisms of brain damage and rational management. Epilepsia. 1982;23(Suppl 1):S29-S41.
16. 16. Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin Neurophysiol. 1995;12:326-342.
17. 17. Maytal J, Shinnar S, Moshe SL, Alvarez LA. Low morbidity and mortality of status epilepticus in children. Pediatrics. 1989;83:323-331.
18. 18. Ramsay RE. Treatment of status epilepticus. Epilepsia. 1993;34(Suppl 1):S71-S81.
19. 19. Bebin M, Bleck TP. New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol. Drugs. 1994;48:153-171.
20. 20. Reves JG, Fragen RJ, Vinik R, Greenblatt DJ. Midazolam: Pharmacology and uses. Anesthesiology. 1985;62:310-324.
21. 21. Raines A, Henderson TR, Swinyard EA, Dretchen KL. Comparison of midazolam and diazepam by the intramuscular route for the control of seizures in a mouse model of status epilepticus. Epilepsia. 1990;31:313-317.
22. 22. Versed prescribing information. Physicians' Desk Reference. Montvale, NJ: Medical Economics Co; 1997:2324-2327.
23. 23. Galvin GM, Jelinek GA. Midazolam: An effective intravenous agent for seizure control. Arch Emerg Med. 1987;4:169-172.
24. 24. Bell DM, Richards G, Dhillon S, et al. A comparative pharmacokinetic study of intravenous and intramuscular midazolam in patients with epilepsy. Epilepsy Res. 1991;10:183-190.
25. 25. Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med. 1992;20:483-488.
26. 26. Parent JM, Lowenstein DH. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology. 1994;44:1837-1840.
27. 27. Weiser HG, Hailemariam S, Regard M, et al. Unilateral limbic epileptic status activity: Stereo EEG, behavioral, and cognitive data. Epilepsia. 1985;26:19-29.
28. 28. Rivera R, Segnini M, Baltodano A, Perez V. Midazolam in the treatment of status epilepticus in children. Crit Care Med. 1993;21:991-994.
29. 29. Kaneko S, Kurahashi K, Fujita S, et al. Potentiation of GABA by midazolam and its therapeutic effect against status epilepticus. Folia Psychiatr Neurol Jpn. 1983;37:307-310.
30. 30. Lemerle J, Daoud P, Moutard ML, et al. Use of intravenous midazolam in status epilepticus in children. Arch Pediatr. 1995;2:848-853.
31. 31. Gherpelli JLD, Luccas FJC, Roitman I, Troster EJ. Midazolam for treatment of refractory neonatal seizures: A case report. Arq Neuro-Psiquiatr. 1994;52:260-262.
32. 32. Dreiffuss FE, Rosman NP, Lloyd JC, et al. A comparison of rectal diazepam gel and placebo for acute, repetitive seizures. NEJM. 1998;338:1869-1875.
33. 33. Mayhue FE. IM midazolam for status epilepticus in the emergency department. Ann Emerg Med. 1988;17:144-146.
34. 34. Jawad S, Oxley J, Wilson J, Richens A. A pharmacodynamic evaluation of midazolam as an antiepileptic compound. J Neurol Neurosurg Psych. 1986;49:1050-1054.
35. 35. Galdames Poblete D, Silva-Rosas C, Aguilera Olivares L. Treatment of status epilepticus with midazolam: Report of four cases. Neurologia. 1994;9:109-111.
36. 36. McDonagh TJ, Jelinek GA, Galvin GM. Intramuscular midazolam rapidly terminates seizures in children and adults. Emerg Med. 1992;4:77-81.
37. 37. Chamberlain JM, Altieri MA, Futterman C, et al. A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care. 1997;13:92-94.
38. 38. Walker MC, Smith SJM, Shorvon SD. The intensive care treatment of convulsive status epilepticus in the UK. Anesthesia. 1995;50:130-135.
39. 39. Galvin GM, Jelinek GA. Successful treatment of 75 patients in status epilepticus with intravenous midazolam. Emerg Med. 1992;4:11-12.
40. 40. Borgeat A, Wilder-Smith OHG, Jallon P, Suter PM. Propofol in the management of refractory status epilepticus: A case report. Intensive Care Med. 1994;20:148-149.
41. 41. Makela JP, Iivanainen M, Pieninkeroinen IP, et al. Seizures associated with propofol anesthesia. Epilepsia. 1993;34:832-835.
42. 42. Yaffe K, Lowenstein DH. Prognostic factors of pentobarbital therapy for a refractory generalized status epilepticus. Neurology. 1993;43:895-900.
43. 43. Backman JT, Olkkola KT, Aranko K, et al. Dose of midazolam should be reduced during diltiazem and verapamil treatments. Br J Clin Pharmacol. 1994;37:221-225.
44. 44. Michalk S, Moncorge C, Fichelle A, et al. Midazolam infusion for basal sedation in intensive care: Absence of accumulation. Intensive Care Med. 1988;15:37-41.